(Q50083304)

24 February 2018

title

R-form LPS, the master key to the activation ofTLR4/MD-2-positive cells (English)

1 reference

24 February 2018

0 references

5

1 reference

24 February 2018

Bruce Beutler

10

object named as

Bruce Beutler

1 reference

24 February 2018

9

Suzanne Mudd

1 reference

24 February 2018

Sosathya Sovath

8

object named as

Sosathya Sovath

1 reference

24 February 2018

author name string

Michael Huber

1

1 reference

24 February 2018

Christoph Kalis

2

1 reference

24 February 2018

Simone Keck

3

1 reference

24 February 2018

Zhengfan Jiang

4

1 reference

24 February 2018

Xin Du

6

1 reference

24 February 2018

Louis Shamel

7

1 reference

24 February 2018

Chris Galanos

11

1 reference

24 February 2018

Marina A Freudenberg

12

1 reference

24 February 2018

language of work or name

English

0 references

publication date

1 March 2006

1 reference

24 February 2018

European Journal of Immunology

published in

1 reference

24 February 2018

volume

36

1 reference

24 February 2018

issue

3

1 reference

24 February 2018

page(s)

701-711

1 reference

24 February 2018

Role of lipopolysaccharide susceptibility in the innate immune response to Salmonella typhimurium infection: LPS, a primary target for recognition of Gram-negative bacteria

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535593

7 January 2021

How we detect microbes and respond to them: the Toll-like receptors and their transducers

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535593

7 January 2021

The molecular pathogenesis of endotoxic shock and organ failure

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535593

7 January 2021

The role of bacteriolysis in the pathophysiology of inflammation, infection and post-infectious sequelae

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535593

7 January 2021

Beneficial or deleterious effects of a preexisting hypersensitivity to bacterial components on the course and outcome of infection.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535593

7 January 2021

Innate immunity: an overview

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535593

7 January 2021

The cells of the allergic response: mast cells, basophils, and eosinophils

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535593

7 January 2021

Signalling through the high-affinity IgE receptor Fc epsilonRI.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535593

7 January 2021

Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535593

7 January 2021

Essential role of MD-2 in LPS responsiveness and TLR4 distribution

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535593

7 January 2021

Role of TLR4/MD-2 and RP105/MD-1 in innate recognition of lipopolysaccharide

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535593

7 January 2021

CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535593

7 January 2021

Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535593

7 January 2021

Soluble CD14-mediated cellular responses to lipopolysaccharide

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535593

7 January 2021

Plasma CD14 decreases monocyte responses to LPS by transferring cell-bound LPS to plasma lipoproteins

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535593

7 January 2021

Acute-phase concentrations of lipopolysaccharide (LPS)-binding protein inhibit innate immune cell activation by different LPS chemotypes via different mechanisms

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535593

7 January 2021

CD14 is required for MyD88-independent LPS signaling.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535593

7 January 2021

Structure of bacterial lipopolysaccharides

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535593

7 January 2021

Induction of human granulocyte chemiluminescence by bacterial lipopolysaccharides

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535593

7 January 2021

Toll-like receptor 4 expression levels determine the degree of LPS-susceptibility in mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535593

7 January 2021

Th2 cytokine production from mast cells is directly induced by lipopolysaccharide and distinctly regulated by c-Jun N-terminal kinase and p38 pathways

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535593

7 January 2021

Recognition of gram-negative bacteria and endotoxin by the innate immune system

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535593

7 January 2021

Lipopolysaccharide induces physical proximity between CD14 and toll-like receptor 4 (TLR4) prior to nuclear translocation of NF-kappa B

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535593

7 January 2021

Protective roles of mast cells against enterobacterial infection are mediated by Toll-like receptor 4

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535593

7 January 2021

IL-9 and IL-13 production by activated mast cells is strongly enhanced in the presence of lipopolysaccharide: NF-kappa B is decisively involved in the expression of IL-9.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535593

7 January 2021

Variable expression of Toll-like receptor in murine innate and adaptive immune cell lines

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535593

7 January 2021

Altered function of murine mast cells in response to lipopolysaccharide and peptidoglycan

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535593

7 January 2021

Toll-like receptor 2 (TLR2) and TLR4 differentially activate human mast cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535593

7 January 2021

Upregulation of mouse CD14 expression in Kupffer cells by lipopolysaccharide

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535593

7 January 2021

Human monocyte CD14 is upregulated by lipopolysaccharide.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535593

7 January 2021

Expression and role of CD14 in mice sensitized to lipopolysaccharide by Propionibacterium acnes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535593

7 January 2021

Increased levels of soluble CD14 in sera of periodontitis patients

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535593

7 January 2021

Increased soluble CD14 levels in BAL fluid in pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535593

7 January 2021

Soluble CD14 levels in the serum, synovial fluid, and cerebrospinal fluid of patients with various stages of Lyme disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535593

7 January 2021

Elevated levels of soluble CD14 in serum of patients with acute Plasmodium falciparum malaria

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535593

7 January 2021

Cerebrospinal fluid levels of soluble CD14 in inflammatory and non-inflammatory diseases of the CNS: upregulation during bacterial infections and viral meningitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535593

7 January 2021

CD14 is an acute-phase protein

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535593

7 January 2021

Soluble CD14 participates in the response of cells to lipopolysaccharide

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535593

7 January 2021

Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535593

7 January 2021

Soluble CD14 mediates lipopolysaccharide-induced intercellular adhesion molecule 1 expression in cultured human gingival fibroblasts

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535593

7 January 2021

Increased Circulating Soluble Cd14 Is Associated With High Mortality In Gram-Negative Septic Shock

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535593

7 January 2021

Expression patterns of the lipopolysaccharide receptor CD14, and the FCgamma receptors CD16 and CD64 on polymorphonuclear neutrophils: data from patients with severe bacterial infections and lipopolysaccharide-exposed cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535593

7 January 2021

Crystal structure of CD14 and its implications for lipopolysaccharide signaling

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535593

7 January 2021

Characterization of the lipid A component of genuine smooth-form lipopolysaccharide

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535593

7 January 2021

Immunological characterization and functional importance of human heart mast cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535593

7 January 2021

Toll-like receptors in cardiovascular diseases

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535593

7 January 2021

Artherosclerosis as an infectious, inflammatory and autoimmune disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535593

7 January 2021

Chlamydia pneumoniaeand atherosclerosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535593

7 January 2021

Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535593

7 January 2021

Electrodialysis of Lipopolysaccharides and Their Conversion to Uniform Salt Forms

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535593

7 January 2021

A New Method for the Extraction of R Lipopolysaccharides

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535593

7 January 2021

Biological activity of synthetic heptaacyl lipid A representing a component of Salmonella minnesota R595 lipid A.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535593

7 January 2021

Bacterial induction of beta interferon in mice is a function of the lipopolysaccharide component

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535593

7 January 2021

Divergent response to LPS and bacteria in CD14-deficient murine macrophages.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535593

7 January 2021

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535593

7 January 2021

Modification of the silver staining technique to detect lipopolysaccharide in polyacrylamide gels

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535593

7 January 2021

Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535593

7 January 2021

The src homology 2-containing inositol phosphatase (SHIP) is the gatekeeper of mast cell degranulation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535593

7 January 2021

Requirement for lipopolysaccharide-responsive macrophages in galactosamine-induced sensitization to endotoxin

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535593

7 January 2021

Targeted disruption of SHIP leads to Steel factor-induced degranulation of mast cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535593

7 January 2021

Identifiers

DOI

10.1002/EJI.200535593

1 reference

24 February 2018

1 reference

24 February 2018